AI assistant
Sending…
Medpace Holdings, Inc. — Director's Dealing 2022
Feb 17, 2022
30442_dirs_2022-02-17_3d091d71-9238-4b9e-83e6-142f19aac809.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Medpace Holdings, Inc. (MEDP)
CIK: 0001668397
Period of Report: 2022-02-15
Reporting Person: EWALD STEPHEN P (General Counsel & Corp. Secy.)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-02-15 | Employee Stock Option (Right to Buy) | $138.87 | A | 23349 | Acquired | 2027-08-15 | Common Stock (23349) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 13854 | Direct |
Footnotes
F1: The option vests on the fourth anniversary of the grant date, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.
More from Medpace Holdings, Inc.
Regulatory Filings
2026
May 19
Interim / Quarterly Report
2026
Apr 23
Regulatory Filings
2026
Apr 22
Annual Report
2026
Apr 1
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Regulatory Filings
2026
Mar 17
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 17